Glaukos Corporation (GKOS) ticks all the boxes for top investors with its surprise performance of -7.15% last month.

On Tuesday, Glaukos Corporation (NYSE: GKOS) opened lower -3.11% from the last session, before settling in for the closing price of $150.01. Price fluctuations for GKOS have ranged from $83.90 to $163.71 over the past 52 weeks.

A company in the Healthcare sector has jumped its sales by 8.27% annually for the last half of the decade. Company’s average yearly earnings per share was noted 19.74% at the time writing. With a float of $53.02 million, this company’s outstanding shares have now reached $55.09 million.

In an organization with 907 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.61%, operating margin of -32.77%, and the pretax margin is -41.24%.

Glaukos Corporation (GKOS) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Glaukos Corporation is 3.84%, while institutional ownership is 101.55%. The most recent insider transaction that took place on Dec 20 ’24, was worth 498,716. In this transaction PRESIDENT & COO of this company sold 3,328 shares at a rate of $149.85, taking the stock ownership to the 102,169 shares. Before that another transaction happened on Dec 20 ’24, when Company’s Director sold 10,000 for $150.28, making the entire transaction worth $1,502,800. This insider now owns 32,336 shares in total.

Glaukos Corporation (GKOS) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 19.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.93% during the next five years compared to -49.95% drop over the previous five years of trading.

Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators

Check out the current performance indicators for Glaukos Corporation (GKOS). In the past quarter, the stock posted a quick ratio of 4.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.24.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.96, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.05 in one year’s time.

Technical Analysis of Glaukos Corporation (GKOS)

Let’s dig in a bit further. During the last 5-days, its volume was 0.48 million. That was inferior than the volume of 0.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.25%. Additionally, its Average True Range was 4.87.

During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 57.61%, which indicates a significant increase from 8.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.57% in the past 14 days, which was lower than the 35.41% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $149.96, while its 200-day Moving Average is $129.56. However, in the short run, Glaukos Corporation’s stock first resistance to watch stands at $148.34. Second resistance stands at $151.35. The third major resistance level sits at $153.70. If the price goes on to break the first support level at $142.99, it is likely to go to the next support level at $140.64. The third support level lies at $137.63 if the price breaches the second support level.

Glaukos Corporation (NYSE: GKOS) Key Stats

There are currently 55,137K shares outstanding in the company with a market cap of 8.01 billion. Presently, the company’s annual sales total 314,710 K according to its annual income of -134,660 K. Last quarter, the company’s sales amounted to 96,670 K and its income totaled -21,410 K.